alexa The Natural History Of Breast Cancers
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

JOINT EVENT:19th Euro Congress on Cancer Science and Therapy & 25th Cancer Nursing & Nurse Practitioners Conference
July 17-19, 2017 Lisbon, Portugal

Alvaro Macieira-Coelho
French National Institute of Health (INSERM), France
Keynote: J Cancer Sci Ther
DOI: 10.4172/1948-5956-C1-104
Abstract
Breast cancers have been extensively studied, which renders them quite representative of the nature of neoplastic disease. While describing the pathogenesis, one has to consider the organism as a whole, the tumor microenvironment, and the tumor cells proper. The permanent evolution of the organism from the embryonic stage up to senescence can create variable vulnerability factors for the growth of breast cancers, influenced by environmental factors. We have found that a population of fibroblasts in connective tissue has abnormal growth characteristics, which shows that the whole organism participates in the neoplastic process. This population of fibroblasts is present long before the cancer becomes apparent. Micro-environmental factors such as genes expressed and factors secreted by stromal cells also influence tumor growth. Gene expression by tumor cells shows that breast cancers are not a single disease and constitute a group of molecularly distinct neoplastic disorders. Finally, during senescence the incidence of breast cancers declines due to tissue, cellular and molecular modifications occurring in the organism during the last developmental stage of the human life span.
Biography

Alvaro Macieira-Coelho is a Research Director at the French National Institute of Health. He received a MD from the University of Lisbon, Portugal, and a PhD from the University of Uppsala Sweden. He did an internship at the University Hospital in Lisbon and was a Research Associate at the Wistar Institute in Philadelphia (USA) and at the Department of Cell Biology of the University of Uppsala (Sweden). He became the Head of the Department of Cell Pathology at the Cancer Institute in Villejuif (France) and was a Visiting Professor at the University of Linkoping (Sweden). He has published 150 papers in professional journals and 9 books on Cancer and Aging. He has received the following awards: Fritz Verzar Prize (University of Vienna, Austria), “Seeds of Science”, Career Prize (Lisbon, Portugal), Dr. Honoris Causa (University of Linkoping, Sweden), Johananof International Visiting Professor (Institute Mario Negri, Milano, Italy).

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords